Recombinant Human ARMC5 Protein (A2-A935), His/Strep tagged
Cat.No. : | ARMC5-0585H |
Product Overview : | Recombinant Human 8His-StrepII-TEV-(GG)-ARMC5(A2-A935 end) Protein was expressed in Insect cell. |
- Specification
- Gene Information
- Related Products
- Download
Description : | Involved in fetal development, T-cell function and adrenal gland growth homeostasis. Negatively regulates adrenal cells survival. Plays a role in steroidogenesis, modulates steroidogenic enzymes expression and cortisol production. |
Source : | Insect cell |
Species : | Human |
Tag : | His/Strep |
Form : | Liquid |
Protein Length : | A2-A935 |
Endotoxin : | < 0.01 EU per μg of the protein |
Purity : | 90% |
Stability : | Samples are stable for up to twelve months from date of receipt at -20 to -80 centigrade. |
Storage : | Store it under sterile conditions at -20 to -80 centigrade. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles. |
Storage Buffer : | Supplied as sterile 50 mM Tris-HCl (pH7.5), 200 mM NaCl, 20% glycerol |
Shipping : | It is shipped out with blue ice. |
Gene Name : | ARMC5 armadillo repeat containing 5 [ Homo sapiens (human) ] |
Official Symbol : | ARMC5 |
Gene ID : | 79798 |
mRNA Refseq : | NM_024742 |
Protein Refseq : | NP_079018 |
UniProt ID : | Q96C12 |
Products Types
◆ Recombinant Protein | ||
ARMC5-446R | Recombinant Rat ARMC5 Protein, His (Fc)-Avi-tagged | +Inquiry |
ARMC5-0584H | Recombinant Human ARMC5 Protein (A2-A935), Tag Free | +Inquiry |
ARMC5-736M | Recombinant Mouse ARMC5 Protein, His (Fc)-Avi-tagged | +Inquiry |
ARMC5-790R | Recombinant Rat ARMC5 Protein | +Inquiry |
ARMC5-790H | Recombinant Human ARMC5 protein, GST-tagged | +Inquiry |
Related Gene
For Research Use Only. Not intended for any clinical use. No products from Creative BioMart may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative BioMart.
Inquiry
- Q&As
- Reviews
Q&As (29)
Ask a questionYes, ARMC5 mutations can be inherited in an autosomal dominant pattern, meaning that individuals with a mutated copy of ARMC5 have a 50% chance of passing the mutation on to their offspring.
The regulation of ARMC5 expression is not well understood. However, studies suggest that ACTH (adrenocorticotropic hormone), which stimulates cortisol production, may influence ARMC5 expression levels.
ARMC5 mutations are primarily associated with PBMAH. However, recent studies have suggested potential links between ARMC5 mutations and other adrenal disorders, such as adrenal adenomas and hyperplasia. Further research is needed to establish these associations conclusively.
With appropriate management and treatment, individuals with ARMC5-related disorders can lead fulfilling lives. However, the specific impact on daily life may vary depending on the severity and progression of the disorder.
As of now, there are no known clinical trials specifically focused on investigating potential treatments for ARMC5-related disorders. However, ongoing research may uncover new therapeutic approaches in the future.
Yes, ARMC5 mutations or loss of expression can be used as diagnostic markers for PBMAH. Genetic testing for ARMC5 mutations can help confirm the diagnosis of this rare adrenal disorder.
Yes, ongoing research is focused on understanding the cellular mechanisms of ARMC5, exploring potential therapeutic targets, and improving diagnostic methods for ARMC5-related disorders.
Mutations or dysfunction in ARMC5 protein can lead to a rare genetic disorder called primary bilateral macronodular adrenal hyperplasia (PBMAH). This condition results in the formation of abnormal nodules in the adrenal glands, leading to overproduction of cortisol and potentially causing Cushing's syndrome.
Yes, genetic testing can detect ARMC5 mutations in adults without symptoms, particularly those with a known family history of ARMC5-related disorders. Testing can help identify carriers and individuals at risk of developing the disorder in the future.
Yes, ARMC5 has been found to interact with several other proteins, including MEN1 (Multiple Endocrine Neoplasia Type 1), a tumor suppressor gene associated with a variety of endocrine tumors.
Currently, there are no targeted therapies or specific medications available for treating ARMC5-related disorders. Management typically involves surgery to remove tumors or nodules causing symptoms and may also involve hormone replacement therapy to normalize hormone levels.
Yes, genetic testing can detect ARMC5 mutations in individuals without symptoms, particularly those with a known family history of ARMC5-related disorders. This testing can help identify carriers and at-risk individuals.
Besides its role in cortisol regulation, ARMC5 protein may have additional functions that are yet to be fully understood. Research suggests its involvement in cell cycle regulation and potentially in DNA repair processes.
Currently, ARMC5 mutations are not part of routine newborn screening programs. However, if there is a known family history of ARMC5-related disorders, genetic testing can be performed on newborns to determine if they have inherited the mutation.
Currently, there are no specific therapeutic interventions targeting ARMC5 protein for PBMAH. Treatment options for PBMAH typically involve surgical removal of the affected adrenal glands or pharmacological management of cortisol levels.
Yes, ARMC5-related disorders can affect both children and adults. Manifestation of symptoms can occur at any age depending on the specific disorder and the presence of tumors or nodules in the endocrine glands.
ARMC5-related disorders are considered rare. The exact prevalence is not well known, but they are thought to be quite rare, with only a small number of reported cases in medical literature.
While the exact causes of ARMC5-related disorders are not completely understood, there is no strong evidence suggesting specific environmental factors that contribute to the development of these disorders. The primary cause is believed to be genetic mutations.
The primary risk factor for developing ARMC5-related disorders is inheriting a mutation in the ARMC5 gene. It is usually inherited in an autosomal dominant manner, meaning that individuals who have one affected parent have a 50% chance of inheriting the mutation.
Some long-term complications or risks associated with ARMC5-related disorders include the development of adrenal insufficiency after tumor removal, recurrence of tumors, and the potential for other endocrine gland abnormalities due to the involvement of ARMC5 in multiple endocrine tissues.
Currently, there are no specific guidelines for surveillance or screening for ARMC5-related disorders. However, individuals with a known family history may benefit from regular medical check-ups and screening for endocrine abnormalities.
Yes, researchers have developed mouse models with ARMC5 gene knockout, which helps in studying its role in adrenal gland development and cortisol regulation.
At present, there is no cure for ARMC5-related disorders. Treatment mainly focuses on managing symptoms and preventing complications through surgical interventions and hormone replacement therapy.
Common symptoms of PBMAH include weight gain, abdominal obesity, high blood pressure, easy bruising, muscle weakness, fatigue, and menstrual irregularities in women.
Yes, there are support groups and organizations that provide resources, information, and support for individuals and families affected by ARMC5-related disorders. Examples include the Pituitary Network Association and the MAGIC Foundation.
Mutations in ARMC5 disrupt its tumor suppressor activity, leading to the formation of abnormal nodules in the adrenal glands. These nodules secrete excess cortisol, resulting in the development of PBMAH.
ARMC5 protein acts as a tumor suppressor and regulates adrenal steroidogenesis by inhibiting the production of cortisol. Loss of ARMC5 function can disrupt this control mechanism, leading to excessive cortisol production.
While lifestyle modifications alone may not be sufficient to manage PBMAH, adopting a healthy lifestyle can help improve overall health and well-being for individuals with the condition. This may include regular exercise, a balanced diet, and stress management techniques.
Yes, genetic testing can detect ARMC5 mutations prenatally through chorionic villus sampling (CVS) or amniocentesis, if there is a known family history or suspicion of the disorder.
Customer Reviews (6)
Write a reviewthe manufacturer can play a vital role in supporting and optimizing the research process.
In WB experiments, the ARMC4 Protein consistently delivers exceptional performance.
Its exceptional purity and integrity ensure clear and reliable bands, enabling accurate detection and quantification of target proteins.
The manufacturer can offer technical support and expertise to guide researchers through the experimental process.
manufacturers offer customization options, such as alternative conjugation methods or tailored formulations, allowing researchers to optimize ARMC5 protein to their specific experimental needs.
This protein has consistently demonstrated outstanding results, making it an indispensable tool in my research endeavors.
Ask a Question for All ARMC5 Products
Required fields are marked with *
My Review for All ARMC5 Products
Required fields are marked with *
Inquiry Basket